Erlozest 150mg - Erlotinib Tablets

Erlozest 150mg - Erlotinib Tablets About

Erlozest 150 mg Tablet is an anticancer medicine containing the active constituent erlotinib. It is used to treat non-small lung cancer (NSCLC) and pancreatic cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. It is usually given in combination with other anticancer medicine, gemcitabine, for patients with metastatic or advanced pancreatic cancers.

Inform the doctor if you use contact lenses, have an intolerance to sugars, have a history of eye problems, or if any medicines are taken for clotting disorders or cholesterol. This medication can cause eye dryness and conjunctivitis and hence patients are advised to inform the history of vision problems, use ofcontact lenses before taking this medication. Erlozest 150 mg Tablet is not recommended for adolescents and children under the age of 18. Do not take this medication with food. Use effective birth control during the treatment and for at least 2 weeks after the last dose.

Patients are advised not to smoke while being treated with Erlozest 150 mg Tablet, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside. Inform the physician if the patient has any symptoms like pain in the eye, blurred vision, cough, fever, shortness of breath, severe abdominal pain, and persistent diarrhea while taking this medicine.

Targeted Therapy for Cancer Management

Erlozest 150mg Tablets are specialized for patients diagnosed with EGFR-positive NSCLC and pancreatic cancer. By inhibiting the EGFR enzyme activity, this medicine helps slow cancer progression and can improve patient outcomes when administered under professional guidance. The treatment plan is tailored to individual patient profiles by healthcare specialists.


Optimal Storage and Shelf Life

To maintain its effectiveness, Erlozest 150mg should be stored below 30C, in a dry, cool place away from light and moisture. Its shelf life of 24 months ensures long-term availability and reliability, making it suitable for consistent therapeutic regimens. Proper storage preserves the potency and safety of the tablets.


High-Quality Manufacturing Standards

Sourced from India, Erlozest 150mg is manufactured following strict quality controls. The product's origin ensures it meets pharmaceutical industry standards and ensures patient safety. Each batch is carefully processed and tested before distribution by suppliers and traders.